|
|
|
| Efficacy of Tacrolimus Combined with Glucocorticoid in Patients with Nephrotic Syndrome and its Effect on Inflammatory Factors |
| TANG Jie |
| The First Affiliated Hospital of Harbin Medical University,Harbin 150000 |
|
|
|
Abstract 【Objective】 To investigate the efficacy of tacrolimus combined with glucocorticoid in the treatment of nephrotic syndrome and the effect on the inflammatory factors. 【Methods】Eighty-six patients with nephrotic syndrome were randomly divided into the experimental group and the control group with 43 cases in each group. Both groups were treated with glucocorticoid, while the experimental group was additionally treated with tacrolimus. The blood lipids [triglyceride (TG), serum total cholesterol (TC), low- density lipoprotein (LDLC), high-density lipoprotein (HDLC)], inflammatory factors [interleukin -1 (IL-1), interleukin -6 (IL-6), tumor necrosis factor alpha (TNF-α)], renal function [blood urea nitrogen (BUN), serum creatinine (SCr), 24h urine protein quantitation] and adverse drug reactions were observed before and after treatment. 【Results】Before treatment, all showed no significant differences between the two groups (P>0.05); After treatment, TG, TC, LDLC, IL-1, IL-6, TNF-α, BUN, SCr and 24h urine protein quantitation decreased significantly while HDLC increased significantly; After treatment, TG, TC, LDLC, IL-1, IL-6, TNF-α, BUN, SCr, 24h urinary protein in the experimental group were significantly lower than those in the control group, HDLC increased significantly, and the difference was significant (P<0.05). There was no significant difference in the incidence of adverse drug reactions between the two groups (P>0.05).【Conclusion】 Tacrolimus combined with glucocorticoid in the treatment of nephrotic syndrome can significantly reduce the expression of inflammatory factors and improve the renal function of patients by effectively regulating the blood lipid levels.
|
|
Received: 20 November 2016
|
|
|
|
|
|
[1] 李易,田鲁,陈健,等.原发性肾病综合征与血小板活化因子水解酶的相关性分析[J].解放军医药杂志,2015,27(5):73-75.
[2] ElieV,Fakhoury M,Deschenes G,et al.Physiopathology of idiopathic nephrotic syndrome:Lessons from glucocorticoids and epigenetic perspectives[J].Pediatric Nephrol,2012,27(8) :1249-1256.
[3] 张秀敏.糖皮质激素受体与儿童激素耐药型肾病综合征研究进展[J].中国小儿急救医学,2013,20(6):647-650.
[4] 杨武.他克莫司预防经内镜逆行胰胆管造影术后胰腺炎的临床研究[J].医学临床研究,2014,36(1):67-69.
[5] Kim SH,Lee SD,Kim YK,et al. Conversion of twice-daily to once-daily tacrolimus is safe in stable adult living donor liver transplantrecipients[J].Hepatobiliary Pancreat Dis Int,2015, 14(4):374-379.
[6] Li SJ, Tu YM, Zhou CS,et al.Risk factors of venous thromboembolism in focal segmental glomerulosclerosis with nephrotic syndrome[J].Clin Exp Nephrol,2015,29(6): 63-66.
[7] 齐海锋.IL-8,IL-1β在原发性肾病综合征的激素抵抗患儿中的诊断价值[J].中国实验诊断学,2012,16(2):334 335.
[8] 叶琨,王浩宇,徐珏,等.他克莫司联合糖皮质激素治疗难治性肾病综合征的临床评估[J].实用医学杂志,2013,29(9):1500-1502.
(本文编辑:王沪湘)[收稿日期] 2016-11-20
|
| [1] |
. [J]. JOURNAL OF CLINICAL RESEARCH, 2017, 34(4): 819-821. |
|
|
|
|
2017, Vol. 34 
